MAPKAP Kinase 2 抗体
(Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2))
This gene encodes a member of the Ser/Thr protein kinase family. This kinase is regulated through direct phosphorylation by p38 MAP kinase. In conjunction with p38 MAP kinase, this kinase is known to be involved in many cellular processes including stress and inflammatory responses, nuclear export, gene expression regulation and cell proliferation. Heat shock protein HSP27 was shown to be one of the substrates of this kinase in vivo. Two transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| MAPKAP Kinase 2 抗体 (pSer272) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (Thr222) | 人 | 兔 Polyclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (Tyr199, Tyr458) | 人, 小鼠, 大鼠, 猴 | 兔 Polyclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (Asn218) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (Asn266) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| Recombinant MAPKAP Kinase 2 抗体 | 人 | 兔 Monoclonal |
|
|
|
| MAPKAP Kinase 2 抗体 | 小鼠 | 兔 Polyclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (AA 266-352) (PE) | 人 | 小鼠 Monoclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (AA 302-400) (PE) | 人 | 小鼠 Monoclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (AA 302-400) (FITC) | 人 | 小鼠 Monoclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (AA 266-352) (APC) | 人 | 小鼠 Monoclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (AA 302-400) (APC) | 人 | 小鼠 Monoclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (AA 266-352) (FITC) | 人 | 小鼠 Monoclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (AA 44-55) | 小鼠 | 山羊 Polyclonal |
|
|
|
| Recombinant MAPKAP Kinase 2 抗体 | 人, 小鼠, 大鼠 | 兔 Monoclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (pThr334) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (pThr222) | 人, 小鼠, 大鼠, 猴 | 兔 Polyclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (pSer272) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (pSer272) | 人 | 兔 Polyclonal |
|
|
|
| MAPKAP Kinase 2 抗体 (Middle Region) | 人, 小鼠, 大鼠, Cow, 兔, 犬, 斑马鱼, 豚鼠, 马 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer272
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Thr222
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠, 猴
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Tyr199, Tyr458
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Asn218
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Asn266
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- R07-1F5
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1F9
- 标记
- PE
- 抗体亚型
- IgG2b kappa
- 抗原表位
- AA 266-352
Primary Antibody
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2B3
- 标记
- PE
- 抗体亚型
- IgG2b kappa
- 抗原表位
- AA 302-400
Primary Antibody
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2B3
- 标记
- FITC
- 抗体亚型
- IgG2b kappa
- 抗原表位
- AA 302-400
Primary Antibody
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1F9
- 标记
- APC
- 抗体亚型
- IgG2b kappa
- 抗原表位
- AA 266-352
Primary Antibody
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2B3
- 标记
- APC
- 抗体亚型
- IgG2b kappa
- 抗原表位
- AA 302-400
Primary Antibody
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1F9
- 标记
- FITC
- 抗体亚型
- IgG2b kappa
- 抗原表位
- AA 266-352
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- 质量等级
- Verified
- 适用
- 小鼠
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 44-55
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IP (Immunoprecipitation: 所列应用)
- 质量等级
- KD Validated
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 300-349, pThr334
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠, 猴
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 188-237, pThr222
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 238-287, pSer272
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠, Cow, 兔, 犬, 斑马鱼, 豚鼠, 马
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Middle Region
Latest Publications for our MAPKAP Kinase 2 抗体
: "Parvovirus B19 NS1 protein induces cell cycle arrest at G2-phase by activating the ATR-CDC25C-CDK1 pathway." in: PLoS pathogens, Vol. 13, Issue 3, pp. e1006266, (2017) (PubMed).
: "P38 mitogen-activated protein kinase promotes dedifferentiation of primary articular chondrocytes in monolayer culture." in: Journal of cellular and molecular medicine, Vol. 17, Issue 4, pp. 508-17, (2013) (PubMed).
: "Mechanical injury of bovine cartilage explants induces depth-dependent, transient changes in MAP kinase activity associated with apoptosis." in: Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society, Vol. 20, Issue 12, pp. 1591-602, (2012) (PubMed).
: "Living donor liver transplantation for hepatocellular carcinoma: a single-center experience in Taiwan." in: Transplantation, Vol. 85, Issue 3, pp. 398-406, (2008) (PubMed).
: "MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation." in: Molecular cell, Vol. 17, Issue 1, pp. 37-48, (2005) (PubMed).
: "Catalysis and function of the p38 alpha.MK2a signaling complex." in: Biochemistry, Vol. 43, Issue 31, pp. 9950-60, (2004) (PubMed).
: "Retaining of the assembly capability of vimentin phosphorylated by mitogen-activated protein kinase-activated protein kinase-2." in: Journal of cellular biochemistry, Vol. 89, Issue 3, pp. 589-602, (2003) (PubMed).
: "Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzyme." in: Structure (London, England : 1993), Vol. 11, Issue 6, pp. 627-36, (2003) (PubMed).
: "Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export." in: The Journal of biological chemistry, Vol. 277, Issue 40, pp. 37401-5, (2002) (PubMed).
: "Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells." in: The Journal of biological chemistry, Vol. 277, Issue 50, pp. 48379-85, (2002) (PubMed).
: "P38 mitogen-activated protein kinase promotes dedifferentiation of primary articular chondrocytes in monolayer culture." in: Journal of cellular and molecular medicine, Vol. 17, Issue 4, pp. 508-17, (2013) (PubMed).
: "Mechanical injury of bovine cartilage explants induces depth-dependent, transient changes in MAP kinase activity associated with apoptosis." in: Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society, Vol. 20, Issue 12, pp. 1591-602, (2012) (PubMed).
: "Living donor liver transplantation for hepatocellular carcinoma: a single-center experience in Taiwan." in: Transplantation, Vol. 85, Issue 3, pp. 398-406, (2008) (PubMed).
: "MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation." in: Molecular cell, Vol. 17, Issue 1, pp. 37-48, (2005) (PubMed).
: "Catalysis and function of the p38 alpha.MK2a signaling complex." in: Biochemistry, Vol. 43, Issue 31, pp. 9950-60, (2004) (PubMed).
: "Retaining of the assembly capability of vimentin phosphorylated by mitogen-activated protein kinase-activated protein kinase-2." in: Journal of cellular biochemistry, Vol. 89, Issue 3, pp. 589-602, (2003) (PubMed).
: "Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzyme." in: Structure (London, England : 1993), Vol. 11, Issue 6, pp. 627-36, (2003) (PubMed).
: "Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export." in: The Journal of biological chemistry, Vol. 277, Issue 40, pp. 37401-5, (2002) (PubMed).
: "Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells." in: The Journal of biological chemistry, Vol. 277, Issue 50, pp. 48379-85, (2002) (PubMed).
Aliases for MAPKAP Kinase 2 抗体
mitogen-activated protein kinase-activated protein kinase 2a (mapkapk2a) 抗体mitogen-activated protein kinase-activated protein kinase 2 L homeolog (mapkapk2.L) 抗体
mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2) 抗体
MAP kinase-activated protein kinase 2 (Mapkapk2) 抗体
mitogen-activated protein kinase-activated protein kinase 2 (Mapkapk2) 抗体
AA960234 抗体
MAPKAP-K2 抗体
mapkapk2 抗体
MAPKAPK2 抗体
MGC78852 抗体
MK-2 抗体
MK2 抗体
Rps6kc1 抗体
wu:fb30e10 抗体
wu:fc56c10 抗体
wu:fi03a01 抗体
您还需要查找其他产品吗？
You are here:
